NIOX Group (LON:NIOX) Stock: Insider Ian Johnson Sells 193,361 Shares

NIOX Group Plc (LON:NIOX) insider Ian Johnson sold 193,361 shares of the firm’s stock in a transaction on Monday, November 2nd. The shares were sold at an average price of GBX 80, for a total transaction of £154,688.80.

NIOX Group Stock Down 0.3%

Shares of NIOX traded down GBX 0.20 during midday trading on Wednesday, reaching GBX 64.20. 720,624 shares of the company were exchanged, compared to its average volume of 904,284. The company has a market cap of £270.20 million, a price-to-earnings ratio of 39.39 and a beta of 0.92. The company has a current ratio of 4.60, a quick ratio of 1.94 and a debt-to-equity ratio of 1.06. NIOX Group Plc has a 1-year low of GBX 53.84 and a 1-year high of GBX 80. The stock has a 50-day moving average price of GBX 67.34 and a 200-day moving average price of GBX 63.13.

NIOX Group (LON:NIOX) last released its quarterly earnings results on Wednesday, September 30th. The company reported GBX 1.41 earnings per share for the quarter. NIOX Group had a return on equity of 10.01% and a net margin of 14.74%. Research analysts expect that NIOX Group Plc will post 1.17 earnings per share for the current year.

About NIOX Group

NIOX Group plc is a medical technology company focused on improving the lives of millions of people suffering from respiratory health issues globally. NIOX develops and markets innovative, non-invasive diagnostic products for chronic airway diseases, primarily asthma and COPD. Its lead product, NIOX VERO®, enables the accurate measurement of fractional exhaled nitric oxide (FeNO), an established biomarker for airway inflammation, supporting better diagnosis, monitoring and management of asthma and COPD in clinical and research settings.

Headquartered in the UK and listed on the London Stock Exchange (ticker: NIOX), the company operates internationally, serving healthcare professionals in over 50 countries.